Gritstone bio, Inc.
GRTS · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $235,676 | $313,668 | $1,014,463 | $148,902 |
| - Cash | $65,285 | $55,498 | $93,287 | $170,056 |
| + Debt | $104,775 | $40,316 | $26,419 | $25,099 |
| Enterprise Value | $275,166 | $298,486 | $947,595 | $3,945 |
| Revenue | $1,331 | $9,269 | $46,717 | $4,037 |
| % Growth | -85.6% | -80.2% | 1,057.2% | – |
| Gross Profit | -$6,260 | -$6,422 | $32,318 | -$84,606 |
| % Margin | -470.3% | -69.3% | 69.2% | -2,095.8% |
| EBITDA | -$126,863 | -$111,892 | -$68,698 | -$98,670 |
| % Margin | -9,531.4% | -1,207.2% | -147.1% | -2,444.1% |
| Net Income | -$138,490 | -$113,127 | -$74,955 | -$104,611 |
| % Margin | -10,405% | -1,220.5% | -160.4% | -2,591.3% |
| EPS Diluted | -1.2 | -1.24 | -0.95 | -2.77 |
| % Growth | 3.2% | -30.5% | 65.7% | – |
| Operating Cash Flow | -$121,648 | -$115,946 | -$50,678 | -$89,102 |
| Capital Expenditures | -$4,572 | -$5,872 | -$5,463 | -$3,515 |
| Free Cash Flow | -$126,220 | -$121,818 | -$56,141 | -$92,617 |